GoodRx
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 551m | 745m | 767m | 750m | 801m | 878m | 975m |
% growth | 42 % | 35 % | 3 % | (2 %) | 7 % | 10 % | 11 % |
EBITDA | (257m) | 48.0m | 65.2m | 109m | 257m | 292m | 338m |
% EBITDA margin | (47 %) | 6 % | 9 % | 15 % | 32 % | 33 % | 35 % |
Profit | (294m) | (25.3m) | (32.8m) | (8.9m) | 42.0m | 85.0m | 119m |
% profit margin | (53 %) | (3 %) | (4 %) | (1 %) | 5 % | 10 % | 12 % |
EV / revenue | 28.1x | 17.1x | 2.3x | 3.6x | 3.8x | 3.1x | 2.8x |
EV / EBITDA | -60.2x | 265.8x | 26.8x | 24.9x | 11.9x | 9.3x | 8.0x |
R&D budget | 61.8m | 126m | 143m | 136m | - | - | - |
R&D % of revenue | 11 % | 17 % | 19 % | 18 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$1.5m | Seed | ||
N/A | Seed | ||
N/A | Seed | ||
* | N/A Valuation: $2.8b | Growth Equity VC | |
* | N/A | Growth Equity VC | |
$60.0m | Growth Equity VC | ||
N/A | $1.1b Valuation: $12.7b 32.6x EV/LTM Revenues 83.9x EV/LTM EBITDA | IPO | |
Total Funding | CAD83.9m |
Related Content
Recent News about GoodRx
EditGoodRx (website: goodrx.com) is a healthcare technology company that focuses on making prescription medications more affordable for consumers. It operates in the U.S. healthcare market, specifically targeting individuals who need prescription drugs but are looking for ways to reduce their out-of-pocket costs. GoodRx serves a wide range of clients, including uninsured individuals, those with high-deductible health plans, and even those with insurance who find that their copays are higher than the discounted prices available through GoodRx.
The core of GoodRx's business model revolves around providing users with access to coupons and discounts for prescription medications. Users can search for their prescribed drugs on the GoodRx website or app, compare prices at different pharmacies, and obtain coupons that can be presented at the pharmacy to receive discounts. These discounts are available at over 70,000 pharmacies across the United States.
GoodRx makes money primarily through referral fees from pharmacies. When a user redeems a coupon at a pharmacy, GoodRx receives a fee from the pharmacy for directing the customer to them. Additionally, GoodRx offers a subscription service called GoodRx Gold, which provides even deeper discounts on medications for a monthly fee. The company also generates revenue through advertising and partnerships with pharmaceutical companies and other healthcare providers.
GoodRx's mission is to make healthcare more accessible and affordable by providing significant savings on prescription medications, offering convenient and affordable care options, and supplying verified health information. The company emphasizes transparency, privacy, and security in its operations, ensuring that user data is protected and used appropriately.
Keywords: prescription discounts, healthcare technology, pharmacy coupons, uninsured savings, drug price comparison, GoodRx Gold, affordable medications, healthcare access, user privacy, U.S. pharmacies.